TrialOrphanet journal of rare diseases2023

Quality of life improvements following one year of setmelanotide in children and adult patients with Bardet-Biedl syndrome: phase 3 trial results.

Elizabeth Forsythe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.